Abstract
When tested against 312 clinical isolates of rapidly growing mycobacteria, the quinolone pipemidic acid correctly separated Mycobacterium chelonae (M. chelonei) from Mycobacterium fortuitum biovar fortuitum but not from biovar peregrinum or the third biovar complex. The new 4-quinolone ciprofloxacin correctly separated all three biovars of M. fortuitum from M. chelonae and appears to provide a better taxonomic test.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Casal M. J., Rodriguez F. C. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents. Ann Microbiol (Paris) 1983 Jan-Feb;134A(1):73–78. doi: 10.1016/0769-2609(83)90105-9. [DOI] [PubMed] [Google Scholar]
- Casal M. J., Rodriguez F. C. Simple, new test for rapid differentiation of the Mycobacterium fortuitum complex. J Clin Microbiol. 1981 May;13(5):989–990. doi: 10.1128/jcm.13.5.989-990.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Collins C. H., Yates M. D., Uttley A. H. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility. J Hyg (Lond) 1985 Dec;95(3):619–621. doi: 10.1017/s002217240006071x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- David H. L., Traore I., Feuillet A. Differential identification of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol. 1981 Jan;13(1):6–9. doi: 10.1128/jcm.13.1.6-9.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lévy-Frébault V., Daffé M., Goh K. S., Lanéelle M. A., Asselineau C., David H. L. Identification of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol. 1983 May;17(5):744–752. doi: 10.1128/jcm.17.5.744-752.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pattyn S. R., Magnusson M., Stanford J. L., Grange J. M. A study of Mycobacterium fortuitum (ranae). J Med Microbiol. 1974 Feb;7(1):67–76. doi: 10.1099/00222615-7-1-67. [DOI] [PubMed] [Google Scholar]
- Silcox V. A., Good R. C., Floyd M. M. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981 Dec;14(6):686–691. doi: 10.1128/jcm.14.6.686-691.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swenson J. M., Wallace R. J., Jr, Silcox V. A., Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother. 1985 Dec;28(6):807–811. doi: 10.1128/aac.28.6.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Dalovisio J. R., Pankey G. A. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother. 1979 Nov;16(5):611–614. doi: 10.1128/aac.16.5.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Swenson J. M., Silcox V. A., Bullen M. G. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis. 1985 Sep;152(3):500–514. doi: 10.1093/infdis/152.3.500. [DOI] [PubMed] [Google Scholar]
- Wallace R. J., Jr, Swenson J. M., Silcox V. A., Good R. C. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol. 1982 Dec;16(6):1003–1006. doi: 10.1128/jcm.16.6.1003-1006.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Welch D. F., Kelly M. T. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother. 1979 Jun;15(6):754–757. doi: 10.1128/aac.15.6.754. [DOI] [PMC free article] [PubMed] [Google Scholar]